Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
LightScalpel is a private U.S. medical device company that designs, manufactures, services, and sells surgical carbon dioxide (CO2) laser systems for soft-tissue procedures. The company focuses on flexible fiber CO2 laser technology used across dentistry, oral surgery, ENT, dermatology, plastic and reconstructive surgery, gynecology, urology, podiatry, and other outpatient specialties. Its marketed product family includes FDA-cleared laser systems such as the LS-1005, LS-2010, and LS-4020, along with handpieces, accessories, education, and service support. LightScalpel emphasizes in-house manufacturing in Bothell, Washington, proprietary ergonomic handpieces, all-metal laser tube technology, and direct sales/service rather than a drug-development pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LightScalpel.